Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

Recent health headlines include FDA's eye safety concerns over GSK's cancer drug, escalating malnutrition rates in Gaza ...

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities is only natural. | With GSK kicking its R&D engine into high gear in ...

India needs to build a much stronger drug discovery ecosystem to compete globally, says former GSK Pharma MD Annaswamy ...

India Business News: HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s first malaria.

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save thousands of children who suffer from malaria.

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners, by ...

Hyderabad: Bharat Biotech will be reducing the price of world's first malaria vaccine RTS.S, developed by GSK, PATH and partners, for children in endemic countries by more than half, to less than $5 ...

Bharat Biotech International and GSK plc in their commitment to Gavi, the Vaccine Alliance will be reducing the price of RTS.S, developed by GSK, PATH and partners, by more than half, to less than $5 ...

LONDON, June 25 (Reuters) - Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they said on Wednesday ...